Effectiveness of Ofatumumab in Real-world Practice

Clinical trial NCT06760624 · COMPLETED

Trial details

NCT number: NCT06760624
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2023-10-24
Primary completion: 2024-01-15
Enrollment: 779

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.